SPTBN1 Heterozygous Mutation and Autism Spectrum Disorder: Is Paternal Inheritance Possible? A Case Report from Türkiye

Year 2025, Volume: 8 Issue: 2, 75 - 78, 15.03.2025

Dilan Aydin Ayva , Selma Tural Hesapçıoğlu , Mehmet Ceylan

https://doi.org/10.19127/bshealthscience.1607535

Abstract

Autism spectrum disorder (ASD) is a neurodevelopmental disorder defined by impairments in social communication and interaction, restricted and repetitive behaviors, and ritualized behavioral patterns. It was reported 70-90% hereditary transmission in ASD. Single gene variants on chromosomes 1, 2, 3, 5, 7, 15, 16 and 22 have been reported to be associated with ASD. SPTBN1 encodes a βII-spectrin, which plays a critical role in the organization of the neuronal cytoskeleton. Variants in the SPTBN1 gene can therefore lead to various neurological diseases. Until now, the SPTBN1 gene located at the 2p16.2 locus has been shown to be associated with both maternal inheritance and de novo mutations. However, to the best of our knowledge, paternal inheritance has not yet been reported. In this study, we present a female autism case with a paternally inherited heterozygous missense mutation in the SPTBN1 gene. Additionally, this case represents the first autism case carrying an SPTBN1 mutation reported from Türkiye.

Keywords

Paternal inheritance, Autism spectrum disorder, SPTBN1, Heterozygous mutation, Neurodevelopmental delay, Whole exome sequencing

Ethical Statement

Written informed consent was obtained from the patient for the case presentation, and necessary information was given to the patient. The research was conducted in accordance with the Principles of the Declaration of Helsinki.

References

• Al-Beltagi M. 2024. Nutritional management and autism spectrum disorder: A systematic review. World J Clin Pediat, 13(4): 99649.
• Cousin MA, Creighton BA, Breau K A, Spillmann RC, Torti E, Dontu S, Tripathi S, Ajit D, Edwards RJ, Afriyie S. 2021. Pathogenic SPTBN1 variants cause an autosomal dominant neurodevelopmental syndrome. Nature Genet, 53(7): 1006-1021.
• Genovese A, Butler MG. 2023. The autism spectrum: behavioral, psychiatric and genetic associations. Genes, 14(3): 677.
• Hirota T, King BH. 2023. Autism spectrum disorder: a review. Jama, 329(2): 157-168.
• Iossifov I, O’roak B, Sanders SJ, Ronemus M, Krumm N, Levy D, Stessman HA, Witherspoon KT, Vives L, Patterson KE. 2014. The contribution of de novo coding mutations to autism spectrum disorder. Nature, 515(7526): 216-221.
• Jung J, Wu Q. 2024. Identification of bone mineral density associated genes with shared genetic architectures across multiple tissues: Functional insights for EPDR1, PKDCC, and SPTBN1. PLoS ONE, 19(4): e0300535.
• Khan A, Bruno L P, Alomar F, Umair M, Pinto AM, Khan AA, Khan A, Saima, Fabbiani A, Zguro K. 2022. SPTBN5, Encoding the βV-spectrin protein, leads to a syndrome of intellectual disability, developmental delay, and seizures. Front Molec Neurosci, 15: 877258.
• Li J, Wang L, Guo H, Shi L, Zhang K, Tang M, Hu S, Dong S, Liu Y, Wang, T. 2017. Targeted sequencing and functional analysis reveal brain-size-related genes and their networks in autism spectrum disorders. Molec Psychiatry, 22(9): 1282-1290.
• Narcisa V, Discenza M, Vaccari E, Rosen-Sheidley B, Hardan AY, Couchon E. 2013. Parental interest in a genetic risk assessment test for autism spectrum disorders. Clin Pediat, 52(2): 139-146.
• Rosenfeld JA, Xiao R, Bekheirnia MR, Kanani F, Parker M J, Koenig MK, van Haeringen A, Ruivenkamp C, Rosmaninho‐Salgado J, Almeida PM. 2021. Heterozygous variants in SPTBN1 cause intellectual disability and autism. Amer J Medic Genet Part A, 185(7): 2037-2045.
• Savatt JM, Myers SM. 2021. Genetic testing in neurodevelopmental disorders. Front Pediat, 9: 526779.
• Srivastava S, Love-Nichols JA, Dies KA, Ledbetter DH, Martin CL, Chung WK, Firth HV, Frazier T, Hansen RL, Prock L. 2019. Meta-analysis and multidisciplinary consensus statement: exome sequencing is a first-tier clinical diagnostic test for individuals with neurodevelopmental disorders. Genet Medic, 21(11): 2413-2421.
• Sun F, Oristaglio J, Levy SE, Hakonarson H, Sullivan N, Fontanarosa J, Schoelles KM. 2015. Genetic testing for developmental disabilities, intellectual disability, and autism spectrum disorder. Agency for Healthcare Research and Quality, Washington, US, pp: 23.
• Tuncay IO, Parmalee NL, Khalil R, Kaur K, Kumar A, Jimale M, Howe JL, Goodspeed K, Evans P, Alzghoul L. 2022. Analysis of recent shared ancestry in a familial cohort identifies coding and noncoding autism spectrum disorder variants. NPJ Genom Medic, 7(1): 13.
• Wray NR, Lin T, Austin J, McGrath JJ, Hickie IB, Murray GK, Visscher PM. 2021. From basic science to clinical application of polygenic risk scores: a primer. JAMA Psychiatry, 78(1): 101-109.
• Yin J, Schaaf CP. 2017. Autism genetics–an overview. Prenatal Diag, 37(1): 14-30.
• Zhou X, Feliciano P, Shu C, Wang T, Astrovskaya I, Hall JB, Obiajulu J U, Wright JR, Murali SC, Xu SX. 2022. Integrating de novo and inherited variants in 42,607 autism cases identifies mutations in new moderate-risk genes. Nature Genet, 54(9): 1305-1319.